Rosenstein J M, More N S
Department of Anatomy, George Washington University Medical Center, Washington, D.C. 20037.
J Comp Neurol. 1994 Dec 8;350(2):229-40. doi: 10.1002/cne.903500207.
The present study examined the immunocytochemical expression of the blood-brain barrier glucose transporter (GLUT-1) in a series of fetal neocortical transplants, autonomic tissue transplants, and stab wounds to the rat brain. GLUT-1 is one of a family of different glucose transporters and is found exclusively on barrier-type endothelial cells. In the brain it is responsible for the regulated facilitative diffusion of glucose across the blood-brain barrier. This investigation is the first to determine if this important molecule is altered during the process of angiogenesis that occurs following neural transplantation procedures or direct brain injury. Beginning in late fetal brain, e.g., E18 and continuing into maturity, GLUT-1 was strongly and exclusively expressed on normal cerebral vessels. In solid fetal central nervous system (CNS) transplants up to around 3 weeks postoperative, GLUT-1 was only weakly expressed, particularly as exemplified by colloidal gold immunostaining when compared with the host. At later times examined, up to 15 months postoperative, GLUT-1 immunoexpression was comparable with the normal adjacent brain. In autonomic tissue transplants, where the vessels do not have a blood-brain barrier, as expected, GLUT-1 was not expressed. In stab wounds, at 1 week there was extensive gliosis, and the injured vessels appeared fragmented and collapsed but still expressed GLUT-1, although to a somewhat lesser extent than normal brain. Between 3 and 6 weeks, GLUT-1 was expressed on tortuous vessels and in apparently fibrillar processes in the wound vicinity with a similar pattern to astrocyte (GFAP) reactivity. These results suggest the occurrence of a down-regulation of GLUT-1 in early transplants, perhaps related to reduced glycolytic activity or transient ischemia, or possibly due to the utilization of alternative energy sources. That GLUT-1 expression was not entirely lost in stab wounds to the mature brain suggests that the protein may be more labile in fetal or perinatal brain than in the adult and may not be affected by direct injury. Coupled with previous transplantation studies that have shown reduced neuronal glycolysis and potential barrier alterations, the reduction of GLUT-1 activity within nearly the identical time frame could indicate a relatively early critical period in cellular metabolism following transplantation of CNS tissue.
本研究检测了血脑屏障葡萄糖转运体(GLUT-1)在一系列大鼠胎儿新皮质移植、自主组织移植及脑刺伤中的免疫细胞化学表达。GLUT-1是不同葡萄糖转运体家族的一员,仅存在于屏障型内皮细胞上。在大脑中,它负责葡萄糖跨血脑屏障的调节性易化扩散。本研究首次确定了在神经移植手术或直接脑损伤后发生的血管生成过程中,这个重要分子是否发生改变。从胎儿晚期大脑开始,例如E18,并持续到成熟阶段,GLUT-1在正常脑血管上强烈且特异性表达。在术后约3周内的实体胎儿中枢神经系统(CNS)移植中,GLUT-1仅微弱表达,与宿主相比,胶体金免疫染色尤为明显。在术后长达15个月的后续检查中,GLUT-1免疫表达与正常相邻脑组织相当。在自主组织移植中,由于血管没有血脑屏障,正如预期的那样,GLUT-1未表达。在脑刺伤中,1周时出现广泛的胶质增生,受损血管显得破碎和塌陷,但仍表达GLUT-1,尽管程度略低于正常脑。在3至6周之间,GLUT-1在曲折的血管上以及伤口附近明显的纤维状突起中表达,其模式与星形胶质细胞(GFAP)反应性相似。这些结果表明在早期移植中GLUT-1出现下调,可能与糖酵解活性降低或短暂性缺血有关,或者可能是由于替代能源的利用。成熟脑刺伤中GLUT-1表达并未完全丧失,这表明该蛋白在胎儿或围产期脑内可能比在成体中更不稳定,且可能不受直接损伤的影响。结合先前的移植研究表明神经元糖酵解减少和潜在的屏障改变,在几乎相同的时间范围内GLUT-1活性的降低可能表明CNS组织移植后细胞代谢中存在一个相对早期的关键时期。